Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Technology Companies: Vicor (VICR), Ceragon Networks (CRNT) and Septerna, Inc. (SEPN)

Tipranks - Tipranks - Tue Apr 21, 7:06AM CDT

There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Vicor (VICR), Ceragon Networks (CRNT) and Septerna, Inc. (SEPN) with bullish sentiments.

Claim 30% Off TipRanks

Vicor (VICR)

Roth MKM analyst Justin Clare reiterated a Buy rating on Vicor today and set a price target of $245.00. The company’s shares closed last Friday at $218.05.

According to TipRanks.com, Clare is a 5-star analyst with an average return of 19.7% and a 59.6% success rate. Clare covers the Industrial Goods sector, focusing on stocks such as Atkore International Group, American Superconductor, and Broadwind Energy. ;'>

Currently, the analyst consensus on Vicor is a Strong Buy with an average price target of $212.50, implying a 1.7% upside from current levels. In a report issued on April 17, Craig-Hallum also maintained a Buy rating on the stock.

See Insiders’ Hot Stocks on TipRanks >>

Ceragon Networks (CRNT)

Roth MKM analyst Scott Searle maintained a Buy rating on Ceragon Networks today and set a price target of $3.75. The company’s shares closed last Friday at $2.52, close to its 52-week low of $2.33.

According to TipRanks.com, Searle is a 5-star analyst with an average return of 17.9% and a 52.3% success rate. Searle covers the Technology sector, focusing on stocks such as Sequans Communications S A, Smith Micro Software, and Digi International. ;'>

Currently, the analyst consensus on Ceragon Networks is a Strong Buy with an average price target of $3.31, representing a 31.9% upside. In a report issued on April 15, Lake Street also reiterated a Buy rating on the stock with a $3.50 price target.

Septerna, Inc. (SEPN)

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Septerna, Inc. today. The company’s shares closed last Friday at $26.13, close to its 52-week high of $28.99.

According to TipRanks.com, Devarakonda is a 5-star analyst with an average return of 18.4% and a 59.0% success rate. Devarakonda covers the Healthcare sector, focusing on stocks such as NewAmsterdam Pharma Company, Madrigal Pharmaceuticals, and Protagonist Therapeutics. ;'>

Septerna, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $42.00, implying a 64.7% upside from current levels. In a report issued on April 6, TipRanks – PerPlexity also upgraded the stock to Buy with a $28.00 price target.

Read More on VICR:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).